AJ Lanigan: Certainly. In Reality, pharma firms are generating big money with treatment options like Keytruda and Opdivo that offer with PD-1 and PD-L1. Here’s the super great aspect: imagine checkpoints as targeted traffic alerts. You don’t want an immune system that’s running wild just like a freight train over waiting for link from Social Bookmarking (3)